Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/060795external-prioritypatent/WO2012168359A1/en
Application filedfiledCritical
Publication of UA109581C2publicationCriticalpatent/UA109581C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Даний винахід стосується сполук, діючих як антагоністи мускаринових рецепторів, так і як агоністи адренергічного рецептора бета2, способів їх отримання, композицій, що включають їх, терапевтичних застосувань і комбінацій з іншими фармацевтично активними інгредієнтами.The present invention relates to compounds that act as muscarinic receptor antagonists as well as beta-2 adrenergic receptor agonists, methods for their preparation, therapeutic compositions and combinations with other pharmaceutically active ingredients.
UAA201314286A2011-06-102012-07-06
COMPOUNDS WITH THE ACTIVITY OF MUSCARIN RECEPTORS ANGONISTS AND BET2 ADRENERGY RECEPTOR AGONISTS
UA109581C2
(en)
Compounds derived from buprenorphine analogs, with activity as agonists and / or opioid receptor antagonists; composition that understands them; its method of preparation; and its use for the treatment or prevention of pain or constipation.
NEW CYCLOGEXYLAMINE DERIVATIVES THAT HAVE AN AGONISTIC ACTIVITY WITH RESPECT TO β2 ADRENERGIC RECEPTOR AND ANTAGONISTIC ACTIVITY WITH RESPECT TO MUSCARINO RECEPTOR
NEW DERIVATIVES AND cyclohexyl- HINUKLIDINILKARBAMATA having agonistic activity towards β2 adrenergic receptor and antagonistic activity against muscarinic receptors M3